A B S T R A C T The possible occurrence of immune complexes (IC) in serum and in cerebrospinal fluid (CSF) has been studied in 36 patients with African trypanosomiasis (Trypanosoma brucei gambiense). In serum, very high levels of IC were detectable by the '25I-Clq-binding and by the conglutinin-binding assays with positive results in 94 and 87%, respectively, of untreated patients. Circulating IC were found in both early and late stages of the disease, without significant quantitative differences; their size was 15-25S. There was a significant negative correlation between C3 values and ClqBA. Our studies suggest that circulating IC occurring during trypanosomiasis may be the expression of a polyclonal B cell activation. Indeed, there was a significant correlation (P < 0.001) between the levels of circulating IC and either the levels of IgM (mean value 12.5±+7.2 mg/ml) or with the levels of rheumatoid factor-like antiimmunoglobulin antibodies that were detected by solid phase radioimmunoassay in 74% of the patients.
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IC were detected in 31 of 35 CSF samples, with a marked elevation in patients with definite involvement of the central nervous system as compared with earlier stages of sleeping sickness. The occurrence of IC in CSF was not related to an impairment of the blood-brain barrier as shown by analysis of CSF/serum albumin ratios. The level of IC in CSF did not correlate with the serum level and, INTRODUCTION The infection of man with Trypanosoma brucei gambiense is responsible for the development of sleeping sickness. It is still a serious health problem in many African countries (1) . Two phases of the disease are generally recognized: first, there is a proliferation of trypanosomes in blood and in lymphoid tissues, then the parasites invade the central nervous system (CNS)1 and induce a meningo-encephalitis. A major feature of trypanosomiasis is an intense proliferation of lymphocytes, particularly involving B cells and leading to an increased polyclonal synthesis of immunoglobulins (2, 3) . This occurs soon after infection. The development of cerebral lesions ' Abbreviations used in this paper: CNS, central nervous system; CSF, cerebrospinal fluid; ClqBA, 1251-Clq binding assay; IC, immune complexes; KgBA, conglutinin binding assay,; Qalb, CSF/serum albumin ratio; RF, rheumatoid factor. responsible for the typical clinical expression of sleeping sickness is a late manifestation of the disease and is associated with the appearance of IgM in the cerebrospinal fluid (CSF), which probably reflects an intracerebral IgM synthesis (4) .
The pathogenesis of the tissue lesions in African trypanosomiasis is still largely unknown. Experimental studies have indicated that there is no direct toxic effect of the parasites in the infected tissues and that the host's immune response plays a major role in the triggering of inflammatory foci (5) . The present investigation has been undertaken in order to analyze the involvement of immune complexes in this disease. Circulating immune complexes (IC) were first studied in relation to the patient's disease stage and to the expression of the polyclonal B cell activation. In particular, the correlation with the occurrence of rheumatoid factor (RF)-like antibodies was studied. IC were also found in CSF and their origin was questioned. The possibility of IC crossing from blood to CSF or of a local formation of IC within the CNS have been considered in relation to the functional state of the blood-brain barrier and to the local synthesis of immunoglobulins in CNS. The usefulness of the quantitation of CSF-IC for stage diagnosis and follow-up of patients with sleeping sickness has also been evaluated. Through these studies on African trypanosomiasis, it has been possible to approach two questions that are also relevant to other human diseases: (a) Does an intense polyclonal B cell activation generate circulating immune complexes in man? (b) Do IC cross an unimpaired blood-brain barrier?
METHODS
Patients. 82 serum samples and 34 cerebrospinal fluid samples from 36 patients with trypanosomiasis were collected in Zaire in the course of the regular activities of the Centre du Controle de la Trypanosomiase. In all the selected patients, the clinical diagnosis was confirmed by the microscopic demonstration of trypanosomes in blood, in lymph node aspiration fluid or in CSF. All these patients also had anti-trypanosome antibodies in serum. They were also submitted to a routine parasitological investigation. For some of our studies, the patients were classified according to the stage of the disease. and CSF samples were obtained before treatment. In a followup study, samples were also obtained during treatment and several months after treatment with melarsoprol (Arsobal, Rhone-Poulenc, Vitry, France). Blood was drawn from patients and allowed to clot for 2 h. After centrifugation, the serum and CSF samples were frozen, stored, and shipped in liquid nitrogen. Control serum samples were obtained in Kinshasa from age-matched hospitalized Zairian patients suffering from schistosomiasis (eight), amebiasis (two), ascariasis (two), hookworms (two), lung cancer (one), and tuberculosis (two). Another group of control sera was obtained from 40 age-matched normal blood donors in Geneva. Five CSF samples were also obtained in patients from Geneva who had to undergo a myelography which requires prior removal of some CSF. These five CSF samples were considered as normal controls since no neurologic disease could be demonstrated in these patients. In addition, nine CSF and corresponding serum samples were obtained from patients hospitalized in Kinshasa for other parasitic diseases (malaria, schistosomiasis, filariasis). Evaluation of the blood-brain barrier status and detection of an intracerebral immunoglobulin synthesis
The CSF/serum concentration ratios (Q) of albumin (alb), IgG, and IgM (Qalb, QIgG, QIgM, respectively) were determined. The relative impairment of the blood-CSF barrier as reflected by an increased permeability to albumin was estimated from the Qalb values, as described by Tibbling et al. (11) . The IgG index (QIgG/Qalb) was determined according to Schliep and Felgenhauer (12) , in order to evaluate the intensity of the local production of IgG in the CSF compartment. The intracerebral IgG synthesis was also calculated using Tourtellotte's formula (13) The assay for detecting antiimmunoglobulin antibodies using polyethylene tubes coated with rabbit IgG was described by Hay et al. (14) and was slightly modified for use in this study.
Statistical analysis
The data were analyzed using the Wilcoxon rank test, linear regression (r), and the Spearman correlation test (R).
RESULTS
Circulating immune complexes and C3 in human trypanosomiasis. A biological activity suggestive of the presence of immune complexes was investigated in serum from 36 patients, using the Clq binding assay (ClqBA) and the conglutinin binding assay (KgBA). There was an increased ClqBA in 94% ofthese patients, with a median value of36% (Fig. 1) . Values of KgBA were also increased in 81% of the patients with a median value of 64 ,ugeq aggregated human gamma globulin/ml (Fig. 1) . In both ClqBA and KgBA, there was a very significant difference between the sleeping sickness group and either the group of other hospitalized African patients (P < 0.001) or the normal European control group (P < 0.001). There was a significant correlation between the results obtained with the two tests (R = 0.51, P < 0.001). The nature of the Clq binding material was further analyzed by ultracentrifugation of six serum samples on sucrose density gradient. The peak ofClqBA was found in 15-25S fractions (Fig. 2) . The ClqBA was also measured in 10 (Fig. 1) .
In the 36 patients studied before treatment, serum C3 levels were measured. A significant decrease was observed in 67% of samples, with a mean value of 62.9+26.3% (Fig. 3) . In other hospitalized African patients, the mean value was 105.4+33%. There was (2) . In 34 patients studied, high IgG and IgM serum levels (34.8±13.6 and 12.5± 7.2 mg/ml, respectively) were observed without any significant difference according to the stage of the disease. Circulating immune complexes were closely associated with the occurrence of polyclonal antibody synthesis. A very significant correlation was found between ClqBA (R = 0.79, P < 0.001) or KgBA (R = 0.69, P < 0.001) and seruim IgM levels (Fig. 4a) and to a lesser degree between ClqBA and serum IgG levels (R = 0.55, P < 0.001). There was no correlation between KgBA values and IgG levels (R = 0.32, NS). One feature of this polyclonal antibody synthesis is the occurrence of RF-like antiimmunoglobulin antibodies. Using a solid-phase radioimmunoassay for IgM-RF, high levels of RF were obtained in 23/31 sera. There was a significant correlation between ClqBA (R = 0.69,P < 0.001)orKgBAvalues(R = 0.61,P < 0.001) and RF levels (Fig. 4b) .
Anti-trypanosome antibodies were detected in all patients' sera. There was no correlation between the titers of IgG or IgM anti-trypanosome antibodies and the IgG and IgM serum levels, nor with the levels of circulating IC (ClqBA and KgBA) ( Table I) .
Immune complexes in cerebrospinal fluid during African trypanosomiasis. Immune complexes were detected by the ClqBA in 31 of 35 cerebrospinal fluid samples in patients with trypanosomiasis (P < 0.001) (Fig. 5) NS). The correlation between Clq-BA and IgG levels allows an evaluation of the relative integrity of the was significant (r = 0.50, P < 0.01).
blood-brain barrier as well as the demonstration of a IgM and/or IgG anti-trypanosome antibodies were local synthesis of IgG and/or IgM in the CSF detected in 13/15 CSF samples tested (titers 1/4-1/64). compartment (11) . The concentration ratios CSF/serum
The origin of CSF immunoglobulins and CSF for albumin (Qalb) has been selected as a marker immune complexes. Comparison between the serum for the overall permeability of all structures that levels and the CSF levels of several serum proteins separate the serum from CSF (12) . In most patients with trypanosomiasis, no or only slight impairment of the CSF blood barrier state was observed (Table II) . In contrast to the relatively moderate changes in the blood/CSF permeability for albumin, high CSF/ serum ratios were observed for IgG (QIgG) and/or IgM (QIgM) in all patients at stage II and III (Table II) . Low molecular weight (7S) IgM was investigated by immunochemical analysis of sucrose density gradient fractions in three CSF samples with a high IgM content. In all three, there was a spreading of IgM in 7 to 19S fractions; in one of them, two IgM peaks were identified in 7 and 19S positions, whereas the corresponding serum samples did not contain 7S IgM. These results were consistent with an intracerebral synthesis of IgG and IgM, which was further suggested by the analysis of the QIgG/Qalb ratios, or "IgG index" according to Tibbling et al. (11) (Fig. 7) . Indeed, this ratio, which does not vary with age in normal individuals (11) , was markedly increased in 10/13 patients at stage II or-III (Table II ). In the remaining two patients, a high CSF/serum IgM ratio was observed. The concentration of locally synthesized IgG in CSF was calculated using Tourtellotte's formula (13) . These values were in the normal range in the CSF samples collected at stage I, but were elevated in 10/13 CSF samples collected from patients at stage II or III. The 3/13 negative samples displayed an elevation of IgM and QIgM suggestive of a local IgM synthesis. Correlations between, on one hand, the levels of circulating IC, detected by the ClqBA and the KgBA and, on the other hand, the levels of IC in CSF, were not significant (Fig. 8) . Several CSF samples were more positive than the corresponding serum samples (Fig. 8) (5, 15) and preliminary hunman studies (16) . The IClike material that appears in most patients from the early stage of infection, can be detected using two different techniques with a significant correlation between the two sets of results. These two techniques, which were based on the reactivity of IC with Clq or of C3-coated IC with conglutinin, had previously been shown to detect a wide range of IC sizes (8) . These data suggest that this material represents in vivo formed IC A localization ofIC in the CNS has been suggested by the demonstration of electron-dense deposits in the basement membrane ofchoroid plexus in patients with systemic lupus erythematosus and in NZBxNZW mice (17) . In addition, deposits of IgG, bovine serum albumin, and C3 were shown in the choroid plexus of rabbits undergoing an acute IC disease (18) . The latter model was associated with a slight alteration in the blood CSF barrier permeability, but IC were usually not detectable in the CSF. In experimental trypanosomiasis, a progressive involvement of the CNS was found parallel to a progressive appearance of electrondense deposits in the endothelial and in the subependymal layers of the choroid plexus basement membrane (15) . Our data demonstrate the presence of IC in CSF during the encephalitis stage of trypanosomiasis in man. We do not think that the occurrence of IC in CSF primarily results from a diffusion from serum to CSF through the blopd brain barrier. First, IC are detectable in serum in large amounts in the few patients studied at the early stage of infection, without a concomitant appearance of IC in CSF. Secondly, at later stages, there is no correlation between the level of circulating IC and that of CSF-IC. In fact, most patients appear to have a normal or only slightly altered blood-brain barrier, which is probably efficient in preventing an appreciable crossing of IC from serum to CSF.
However, one cannot entirely exclude the possibility that an active equilibrium may be involved in the observed picture of a blood-brain barrier for IC.
The appearance of IC in CSF at the encephalitic stage of African trypanosomiasis was closely associated with increased IgG and/or IgM levels in CSF. There was a dissociation between a moderate increase of the CSF/serum albumin ratio and high values of the CSF/serum IgG or IgM ratios. This leads to high values of "IgG index" which indicate that the majority of these immunoglobulins is synthesized within the CNS compartment (11) . The quantitation of locally synthesized IgG in CSF was carried out using Tourtellotte's formula (13) , which can be used when the blood-brain barrier is not too altered (CSF/serum albumin ratios lower than 10 X 10-3) (19) . This is the case in 14/16 of our patients (Table I ). The elevation of intracerebral IgG synthesis is comparable with that observed in patients with subacute sclerosing panencephalitis and many reflect a similar reaction to the infectious process (19) . This increased IgG synthesis, which is concomitant with the occurrence of trypanosomes in CSF, may reflect an immune response to trypanosome antigens, as suggested by the relatively high levels of antitrypanosome antibodies in CSF, or to some autoantigens. It may also depend on an oligoclonal or polyclonal B cell activation in the CNS compartment.
Therefore, IC appearing in CSF are probably formed locally and may involve trypanosome antigens or autoantigens such as IgG or CNS antigens.
A local formation of IC would be consistent with the observed correlation between the level of Clq-BA and the level of the IgG index. One should note that IC have also been demonstrated in CSF in patients with subacute sclerosing panencephalitis or multiple sclerosis (20) .
The detection of IC in CSF during trypanosomiasis appears as a potentially useful marker for the early diagnosis of cerebral involvement in this disease and for the persistence of CNS infection during therapy. The significance of these results should also be considered in relation to the evaluation of the CNS involvement in systemic lupus erythematosus and other IC diseases.
